GlassScriptPhysician profile
Patrick S Agnew
NPI 1265420756
$21,537.54
in general payments reported to CMS, 2019-2025
41 companies · $1,049 in 2025
The $1,049 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,835 · 2020: $4,488 · 2021: $4,235 · 2022: $5,676 · 2023: $3,194 · 2024: $1,060 · 2025: $1,049.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,039 · Education: $1,800 · Travel and Lodging: $256 · Honoraria: $208.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,039.41 |
| Education | $1,800.00 |
| Travel and Lodging | $256.12 |
| Honoraria | $208.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $15,414.00 | 2019-2025 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Stryker Corporation | $1,963.34 | 2019-2025 | Citrefix, Variax, Ortholoc 3di |
| Smith+Nephew, INC. | $392.29 | 2019-2025 | Collagenase Santyl, Stravix, Grafix Pl |
| Depuy Synthes Sales INC. | $318.68 | 2019-2023 | Na |
| Convatec INC. | $285.02 | 2021-2025 | |
| Paratek Pharmaceuticals, INC. | $228.40 | 2021-2025 | Nuzyra |
| Medtronic, INC. | $219.61 | 2024 | Intellis Adaptivestim |
| Pacira Pharmaceuticals Incorporated | $208.00 | 2023 | Exparel |
| Organogenesis INC. | $202.33 | 2019-2025 | Puraply, Puraply Wound Matrix |
| Allergan, INC. | $164.48 | 2019-2020 | |
| Globus Medical, INC. | $160.38 | 2025 | Senza |
| Misonix INC | $158.81 | 2019 | |
| Nevro Corp. | $149.07 | 2021-2023 | Senza |
| Horizon Therapeutics Plc | $146.64 | 2020-2022 | |
| Medartis INC. | $128.92 | 2019 |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $128.81 | 2021-2023 | Dalvance |
| Anika Therapeutics, INC. | $126.79 | 2023 | Toe Motion, Tactoset, Twist |
| Orthofix Medical, INC. | $124.69 | 2019 | |
| In2bones USA, LLC | $105.71 | 2020-2021 | |
| Melinta Therapeutics, LLC | $95.32 | 2019-2022 | |
| Bioventus LLC | $91.37 | 2019-2025 | Exogen Ultrasound Bone Healing System, Xcell, Exogen Ultrasound Bone Healing System |
| Acell, INC. | $67.81 | 2019-2020 | |
| Curonix LLC | $67.59 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Paragon 28, INC. | $59.22 | 2019 | |
| Heron Therapeutics, INC. | $56.18 | 2021 | |
| Wright Medical Technology, INC. | $50.98 | 2019 | |
| Abbott Laboratories | $50.58 | 2023-2024 | Proclaim |
| Next Science LLC | $48.73 | 2023 | Surgx, Blastx, Xperience |
| Merck Sharp & Dohme LLC | $47.04 | 2019 | |
| Fidia Pharma USA INC. | $37.61 | 2019 | |
| Integra Lifesciences Corporation | $33.10 | 2020 | |
| Lifenet Health | $30.28 | 2023-2025 | Theragenesis Wound Matrix |
| Avita Medical Americas, LLC | $29.84 | 2023 | Recell |
| Averitas Pharma INC. | $25.13 | 2024 | Qutenza |
| Hikma Pharmaceuticals USA | $19.55 | 2019 | |
| Arthrosurface Incorporated | $19.36 | 2025 | Toe Motiontm |
| Sanara Medtech INC. | $19.14 | 2022 | |
| Reprise Biomedical, INC. | $16.68 | 2025 | Miro3d |
| Medela LLC | $15.99 | 2020 | |
| Tactile Systems Technology INC | $15.57 | 2020 | |
| Dynasplint Systems INC. | $14.50 | 2025 | Dynasplint |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Agnew listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.